Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma

A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology oncology research 2005-01, Vol.11 (2), p.92-97
Hauptverfasser: Simsa, Peter, Teillaud, Jean-Luc, Stott, David I, Tóth, József, Kotlan, Beatrix
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 97
container_issue 2
container_start_page 92
container_title Pathology oncology research
container_volume 11
creator Simsa, Peter
Teillaud, Jean-Luc
Stott, David I
Tóth, József
Kotlan, Beatrix
description A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B cells have hardly been investigated in this respect, although high cellular B-cell infiltration has been correlated with improved patients' survival in some breast carcinomas. This led to our objectives to study variable region gene usage of the tumor-infiltrating B cells in different breast carcinoma types. By defining the immunoglobulin repertoire of the tumor-infiltrating B lymphocytes in the most common invasive ductal carcinoma (IDC) of the breast we compared it to the rare medullary breast carcinoma (MBC). After phenotyping infiltrating ductal carcinomas, B cells were obtained from tumor tissue by microdissection technique. Numerous rearranged TIL-B immunoglobulin heavy chain V genes (VH) were amplified, cloned, sequenced, and comparatively analyzed. Some characteristics were found for both breast carcinoma types. The immunoglobulins produced by TIL-B in ductal carcinoma are highly matured and oligoclonal. We conclude that Ig variable region gene usage reveals similar and distinguishable characteristics of TIL-B immunoglobulin repertoires, which are representative of the nature of the immune responses in invasive ductal and medullary breast carcinomas.
doi_str_mv 10.1007/BF02893374
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68012226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2786917723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-bff98b47ab11bfeafde4a003d0fe18ba21dcf7f0885afd55ebf3d257b7a1b9153</originalsourceid><addsrcrecordid>eNp90U2L1jAQB_AgivuiFz-ABAQPC9VM0jbN0V1cFRa8rOcyaSclS5usSfOA39487AMLHjzNwPwYZvgz9g7EJxBCf76-FXIwSun2BTuHTslGDkK_rL0E07Sm68_YRc4PouLe9K_ZGXTGmCrP2XJftpgaH5xf94S7Dwu_5hOtK_fbVkJc1mjL6gM_YPJoV-KJFh8DXygQLxkX4nXqwwGzPxCfy7Tjym0izDufME0-xA3fsFcO10xvT_WS_br9en_zvbn7-e3HzZe7ZlIt7I11zgy21WgBrCN0M7UohJqFIxgsSpgnp50Yhq7Ouo6sU7PstNUI9vjRJfv4tPcxxd-F8j5uPh_fwUCx5LEfBEgp-wo__AMfYkmh3jZKPfQGtJbqfwoAVD1DaFPV1ZOaUsw5kRsfk98w_RlBjMeIxueIKn5_WlnsRvMzPWWi_gJSgYyS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1113885079</pqid></control><display><type>article</type><title>Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Simsa, Peter ; Teillaud, Jean-Luc ; Stott, David I ; Tóth, József ; Kotlan, Beatrix</creator><creatorcontrib>Simsa, Peter ; Teillaud, Jean-Luc ; Stott, David I ; Tóth, József ; Kotlan, Beatrix</creatorcontrib><description>A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B cells have hardly been investigated in this respect, although high cellular B-cell infiltration has been correlated with improved patients' survival in some breast carcinomas. This led to our objectives to study variable region gene usage of the tumor-infiltrating B cells in different breast carcinoma types. By defining the immunoglobulin repertoire of the tumor-infiltrating B lymphocytes in the most common invasive ductal carcinoma (IDC) of the breast we compared it to the rare medullary breast carcinoma (MBC). After phenotyping infiltrating ductal carcinomas, B cells were obtained from tumor tissue by microdissection technique. Numerous rearranged TIL-B immunoglobulin heavy chain V genes (VH) were amplified, cloned, sequenced, and comparatively analyzed. Some characteristics were found for both breast carcinoma types. The immunoglobulins produced by TIL-B in ductal carcinoma are highly matured and oligoclonal. We conclude that Ig variable region gene usage reveals similar and distinguishable characteristics of TIL-B immunoglobulin repertoires, which are representative of the nature of the immune responses in invasive ductal and medullary breast carcinomas.</description><identifier>ISSN: 1219-4956</identifier><identifier>EISSN: 1532-2807</identifier><identifier>DOI: 10.1007/BF02893374</identifier><identifier>PMID: 15999153</identifier><language>eng</language><publisher>Switzerland: Springer Nature B.V</publisher><subject>B-Lymphocytes - immunology ; Brain Stem Neoplasms - immunology ; Brain Stem Neoplasms - pathology ; Breast cancer ; Breast carcinoma ; Breast Neoplasms - immunology ; Breast Neoplasms - pathology ; Carcinoma, Ductal, Breast - immunology ; Carcinoma, Ductal, Breast - pathology ; Gene Rearrangement, B-Lymphocyte, Heavy Chain ; Genes ; Genes, Immunoglobulin ; Humans ; Immune system ; Immunoglobulin Variable Region - genetics ; Immunoglobulins ; Invasiveness ; Lymphocytes B ; Lymphocytes T ; Lymphocytes, Tumor-Infiltrating - immunology ; Metastases ; Neoplasm Invasiveness - pathology ; Oncology ; Pathology ; Phenotyping ; Retrospective Studies ; Solid tumors ; T cell receptors ; Tumor-infiltrating lymphocytes ; Tumors ; Variable region</subject><ispartof>Pathology oncology research, 2005-01, Vol.11 (2), p.92-97</ispartof><rights>Arányi Lajos Foundation 2005</rights><rights>Arányi Lajos Foundation 2005.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-bff98b47ab11bfeafde4a003d0fe18ba21dcf7f0885afd55ebf3d257b7a1b9153</citedby><cites>FETCH-LOGICAL-c341t-bff98b47ab11bfeafde4a003d0fe18ba21dcf7f0885afd55ebf3d257b7a1b9153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15999153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simsa, Peter</creatorcontrib><creatorcontrib>Teillaud, Jean-Luc</creatorcontrib><creatorcontrib>Stott, David I</creatorcontrib><creatorcontrib>Tóth, József</creatorcontrib><creatorcontrib>Kotlan, Beatrix</creatorcontrib><title>Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma</title><title>Pathology oncology research</title><addtitle>Pathol Oncol Res</addtitle><description>A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B cells have hardly been investigated in this respect, although high cellular B-cell infiltration has been correlated with improved patients' survival in some breast carcinomas. This led to our objectives to study variable region gene usage of the tumor-infiltrating B cells in different breast carcinoma types. By defining the immunoglobulin repertoire of the tumor-infiltrating B lymphocytes in the most common invasive ductal carcinoma (IDC) of the breast we compared it to the rare medullary breast carcinoma (MBC). After phenotyping infiltrating ductal carcinomas, B cells were obtained from tumor tissue by microdissection technique. Numerous rearranged TIL-B immunoglobulin heavy chain V genes (VH) were amplified, cloned, sequenced, and comparatively analyzed. Some characteristics were found for both breast carcinoma types. The immunoglobulins produced by TIL-B in ductal carcinoma are highly matured and oligoclonal. We conclude that Ig variable region gene usage reveals similar and distinguishable characteristics of TIL-B immunoglobulin repertoires, which are representative of the nature of the immune responses in invasive ductal and medullary breast carcinomas.</description><subject>B-Lymphocytes - immunology</subject><subject>Brain Stem Neoplasms - immunology</subject><subject>Brain Stem Neoplasms - pathology</subject><subject>Breast cancer</subject><subject>Breast carcinoma</subject><subject>Breast Neoplasms - immunology</subject><subject>Breast Neoplasms - pathology</subject><subject>Carcinoma, Ductal, Breast - immunology</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Gene Rearrangement, B-Lymphocyte, Heavy Chain</subject><subject>Genes</subject><subject>Genes, Immunoglobulin</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunoglobulin Variable Region - genetics</subject><subject>Immunoglobulins</subject><subject>Invasiveness</subject><subject>Lymphocytes B</subject><subject>Lymphocytes T</subject><subject>Lymphocytes, Tumor-Infiltrating - immunology</subject><subject>Metastases</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Phenotyping</subject><subject>Retrospective Studies</subject><subject>Solid tumors</subject><subject>T cell receptors</subject><subject>Tumor-infiltrating lymphocytes</subject><subject>Tumors</subject><subject>Variable region</subject><issn>1219-4956</issn><issn>1532-2807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp90U2L1jAQB_AgivuiFz-ABAQPC9VM0jbN0V1cFRa8rOcyaSclS5usSfOA39487AMLHjzNwPwYZvgz9g7EJxBCf76-FXIwSun2BTuHTslGDkK_rL0E07Sm68_YRc4PouLe9K_ZGXTGmCrP2XJftpgaH5xf94S7Dwu_5hOtK_fbVkJc1mjL6gM_YPJoV-KJFh8DXygQLxkX4nXqwwGzPxCfy7Tjym0izDufME0-xA3fsFcO10xvT_WS_br9en_zvbn7-e3HzZe7ZlIt7I11zgy21WgBrCN0M7UohJqFIxgsSpgnp50Yhq7Ouo6sU7PstNUI9vjRJfv4tPcxxd-F8j5uPh_fwUCx5LEfBEgp-wo__AMfYkmh3jZKPfQGtJbqfwoAVD1DaFPV1ZOaUsw5kRsfk98w_RlBjMeIxueIKn5_WlnsRvMzPWWi_gJSgYyS</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Simsa, Peter</creator><creator>Teillaud, Jean-Luc</creator><creator>Stott, David I</creator><creator>Tóth, József</creator><creator>Kotlan, Beatrix</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050101</creationdate><title>Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma</title><author>Simsa, Peter ; Teillaud, Jean-Luc ; Stott, David I ; Tóth, József ; Kotlan, Beatrix</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-bff98b47ab11bfeafde4a003d0fe18ba21dcf7f0885afd55ebf3d257b7a1b9153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>B-Lymphocytes - immunology</topic><topic>Brain Stem Neoplasms - immunology</topic><topic>Brain Stem Neoplasms - pathology</topic><topic>Breast cancer</topic><topic>Breast carcinoma</topic><topic>Breast Neoplasms - immunology</topic><topic>Breast Neoplasms - pathology</topic><topic>Carcinoma, Ductal, Breast - immunology</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Gene Rearrangement, B-Lymphocyte, Heavy Chain</topic><topic>Genes</topic><topic>Genes, Immunoglobulin</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunoglobulin Variable Region - genetics</topic><topic>Immunoglobulins</topic><topic>Invasiveness</topic><topic>Lymphocytes B</topic><topic>Lymphocytes T</topic><topic>Lymphocytes, Tumor-Infiltrating - immunology</topic><topic>Metastases</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Phenotyping</topic><topic>Retrospective Studies</topic><topic>Solid tumors</topic><topic>T cell receptors</topic><topic>Tumor-infiltrating lymphocytes</topic><topic>Tumors</topic><topic>Variable region</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simsa, Peter</creatorcontrib><creatorcontrib>Teillaud, Jean-Luc</creatorcontrib><creatorcontrib>Stott, David I</creatorcontrib><creatorcontrib>Tóth, József</creatorcontrib><creatorcontrib>Kotlan, Beatrix</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology oncology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simsa, Peter</au><au>Teillaud, Jean-Luc</au><au>Stott, David I</au><au>Tóth, József</au><au>Kotlan, Beatrix</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma</atitle><jtitle>Pathology oncology research</jtitle><addtitle>Pathol Oncol Res</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>11</volume><issue>2</issue><spage>92</spage><epage>97</epage><pages>92-97</pages><issn>1219-4956</issn><eissn>1532-2807</eissn><abstract>A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B cells have hardly been investigated in this respect, although high cellular B-cell infiltration has been correlated with improved patients' survival in some breast carcinomas. This led to our objectives to study variable region gene usage of the tumor-infiltrating B cells in different breast carcinoma types. By defining the immunoglobulin repertoire of the tumor-infiltrating B lymphocytes in the most common invasive ductal carcinoma (IDC) of the breast we compared it to the rare medullary breast carcinoma (MBC). After phenotyping infiltrating ductal carcinomas, B cells were obtained from tumor tissue by microdissection technique. Numerous rearranged TIL-B immunoglobulin heavy chain V genes (VH) were amplified, cloned, sequenced, and comparatively analyzed. Some characteristics were found for both breast carcinoma types. The immunoglobulins produced by TIL-B in ductal carcinoma are highly matured and oligoclonal. We conclude that Ig variable region gene usage reveals similar and distinguishable characteristics of TIL-B immunoglobulin repertoires, which are representative of the nature of the immune responses in invasive ductal and medullary breast carcinomas.</abstract><cop>Switzerland</cop><pub>Springer Nature B.V</pub><pmid>15999153</pmid><doi>10.1007/BF02893374</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1219-4956
ispartof Pathology oncology research, 2005-01, Vol.11 (2), p.92-97
issn 1219-4956
1532-2807
language eng
recordid cdi_proquest_miscellaneous_68012226
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects B-Lymphocytes - immunology
Brain Stem Neoplasms - immunology
Brain Stem Neoplasms - pathology
Breast cancer
Breast carcinoma
Breast Neoplasms - immunology
Breast Neoplasms - pathology
Carcinoma, Ductal, Breast - immunology
Carcinoma, Ductal, Breast - pathology
Gene Rearrangement, B-Lymphocyte, Heavy Chain
Genes
Genes, Immunoglobulin
Humans
Immune system
Immunoglobulin Variable Region - genetics
Immunoglobulins
Invasiveness
Lymphocytes B
Lymphocytes T
Lymphocytes, Tumor-Infiltrating - immunology
Metastases
Neoplasm Invasiveness - pathology
Oncology
Pathology
Phenotyping
Retrospective Studies
Solid tumors
T cell receptors
Tumor-infiltrating lymphocytes
Tumors
Variable region
title Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A31%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor-infiltrating%20B%20cell%20immunoglobulin%20variable%20region%20gene%20usage%20in%20invasive%20ductal%20breast%20carcinoma&rft.jtitle=Pathology%20oncology%20research&rft.au=Simsa,%20Peter&rft.date=2005-01-01&rft.volume=11&rft.issue=2&rft.spage=92&rft.epage=97&rft.pages=92-97&rft.issn=1219-4956&rft.eissn=1532-2807&rft_id=info:doi/10.1007/BF02893374&rft_dat=%3Cproquest_cross%3E2786917723%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1113885079&rft_id=info:pmid/15999153&rfr_iscdi=true